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Abstract
Background
The efferent dorsal motor nucleus of the vagal nuclei complex may degenerate early in the
course of Parkinson’s disease (PD), while efferent nucleus ambiguous, the principal source
of parasympathetic vagal neurons innervating the heart, and afferent somatosensory nuclei
remain intact.
Objective
To obtain neurophysiological evidence related to this pattern, we tested processing of affer-
ent sensory information transmitted via the auricular branch of the vagus nerve (ABVN)
which is known to be connected to autonomic regulation of cardiac rhythm.
Methods
In this cross-sectional observational study, we recorded (i) somatosensory evoked poten-
tials (ABVN-SEP) and (ii) cutaneo-cardioautonomic response elicited by stimulation of the
ABVN (modulation of heart-rate variability (HRV index; low frequency power, ln(LF), high
frequency power, ln(HF); ln(LF/HF) ratio)) in 50 PD patients and 50 age and sex matched
healthy controls. Additionally, auditory evoked potentials and trigeminal nerve SEP
were assessed.
Results
Neither ABVN-SEP nor any of the other functional brainstem parameters differed between
patients and controls. Although HRV index was decreased in PD patients, modulation of ln
(LF/HF) by ABVN-stimulation, likely indicating cardiac parasympathetic activation, did not
differ between both groups.
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Conclusions
Findings do not point to prominent dysfunction of processing afferent information from
ABVN and its connected parasympathetic cardiac pathway in PD. They are consistent with
the known pattern of degeneration of the vagal nuclei complex of the brainstem.
Introduction
Although Parkinson’s disease (PD) presents principally as a movement disorder and is mainly
characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta,
it has been claimed that other brainstem nuclei such as the dorsal motor nucleus (DMN) of the
vagus nerve (VN) may be involved early in the course of the disease [1]. The efferent DMN is
part of the vagal nuclei complex (Fig. 1). This complex additionally comprises the efferent nu-
cleus ambiguous and afferent nuclei, namely the solitary nucleus. The VN also includes axons
which converge onto the spinal trigeminal nucleus [2]. The DMNmainly innervates enteric
neurons. In contrast, cardiac function is controlled by the nucleus ambiguous and, with possi-
bly smaller contributions, by the DMN, with differential functional topography of left and
right brainstem vagal nuclei [3,4].
Fig 1. Schematic illustration of the vagal nuclei complex and its afferents and efferents.
doi:10.1371/journal.pone.0120786.g001
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Neuronal degeneration in PD is believed to affect the DMN [1,5] and, in part, the visceroaf-
ferent solitary nucleus [6], whereas the nucleus ambiguous and the somatosensory nuclei are
spared [6,7]. From a clinical point of view, degeneration of the DMNmay in part be responsi-
ble for autonomic, gastrointestinal, but also cardiac dysfunction, symptoms that often already
occur in a premotor period of PD [8].
One way of addressing integrity of the vagal nuclei complex is by recording somatosensory
evoked potentials (SEP) after stimulation of the auricular branch of vagus nerve (ABVN,
ABVN-SEP, [9]). On electric stimulation of ABVN in the external auditory meatus, a specific
neuronal response can be recorded as bipolar evoked far field potentials at the scalp [9–13].
ABVN-SEP potentials occur at millisecond latencies similar to early auditory evoked potentials
(AEP), indicating that they may originate from brainstem vagal nuclei [9]. Patients with Alz-
heimer’s disease (AD) showed prolonged latencies [13], whereas patients with vascular demen-
tia did not [12]. These results are in line with degeneration of the vagal nuclei complex in the
course of AD [14]. Given the above mentioned pattern of degeneration in PD, sparing of the
somatosensory nuclei would predict that ABVN-SEP should remain unaffected in PD, a con-
clusion challenged by a single pilot study from our lab [11].
Animal and human studies have revealed evidence for anatomic and functional cutaneo-
cardioautonomic connections, mediated by the ABVN [15–19]. We, therefore, rationed that
ABVN stimulation may also offer an opportunity to probe autonomic functions of the vagal
nuclei complex in PD, apart from providing insight into brainstem processing of circumscribed
somatosensory afferents.
Thus, recording of ABVN-SEP combined with ABVN-mediated cardiac autonomic modu-
lation allowed us to address the following two questions: Are somatosensory efferents part of
the degeneration affecting the vagal nuclei complex and are cutaneo-cardioautonomic reflexes
compromised in PD? The answers to these questions may provide important information with
relevance to the extent and functional consequences of the degeneration of the vagal nuclei
complex pathology in PD.
Subjects and Methods
Standard protocol approvals, registrations, and patient consents
The study was approved by the Ethics Committee of the Medical Faculty of the University of
Leipzig (reference no.: 232-09-28092009) and all participants gave their written
informed consent.
Demographic and clinical data
A population of 50 patients with a clinical diagnosis of PD according to the British brain bank
criteria [20] was recruited from patients treated at the Department of Neurology of the Univer-
sity of Leipzig. Exclusion criteria were deep brain stimulation, a clinical history of stroke or
traumatic brain injury. All patients, except one, were on antiparkinsonian medication. Fifty
healthy, age and sex matched subjects with normal results on neurological examination were
recruited as a healthy control group (CTRL). Exclusion criteria for CTRL were history of
stroke, traumatic brain injury or neurodegenerative disease, and clinical signs of PD. The Mon-
treal Cognitive Assessment (MoCa) was used for assessment of cognition [21].
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Auricular branch of vagus nerve somatosensory evoked potentials
(ABVN-SEP)
Assessment of the ABVN-SEP was done as reported by Fallgatter and co-workers [10,9]. In
brief, for transcutaneous electric stimulation of the left and right ABVN the stimulation elec-
trodes (custom-made fine silver wires) were attached to the skin of the inner side of the tragus
at the outer ventral edge of the external auditory meatus. ABVN-SEP were elicited using elec-
tric stimuli (electric square impulses of 0.1 ms duration, stimulation intensity 8 mA, frequency
0.5 Hz) on each side.
Evoked potentials were recorded bipolarly from Fz–F3, C3-F3, O1-T3 and Cz-A1 (left
ABVN), and Fz–F4, C4-F4, O2-T4 and Cz-A2 (right ABVN) according to the international
10–20 system (Fig. 2). One hundred artifact-free epochs (band-pass filter 0.1 Hz −1 kHz, arti-
fact criterion ± 40 μV, analysis time 20 ms), were collected and averaged using a conventional
EMG/EP-system (NeuroConn, Germany) at least two times. Peak latencies (P1, N1, P2) and
peak-to-peak latencies of early components (P1-N1, N1-P2) and peak-to-peak amplitudes
(P1-N1, N1-P2) were determined semi-automatically and used for further statistical analyses.
The analysis was performed offline with the investigator (D.W.) blinded for the identity and
clinical status of the participants.
Auditory evoked potentials (AEP) and trigeminal nerve somatosensory
evoked potentials (TrigN-SEP)
AEP were generated by a click stimulus (minimum 2  500 clicks on each side, stimulation du-
ration 0.1 ms, frequency 15 Hz, intensity 80 dB) via headphones and recorded bipolarly from
Fig 2. Schematic illustration of bipolar recordings from the scalp (10–20 system).
doi:10.1371/journal.pone.0120786.g002
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A1-Cz (left) and A2-Cz (right), respectively. TrigN-SEP were recorded bipolarly from C5-Fz
(left) and C6-Fz (right) and generated by transcutaneous electric stimulation of the trigeminal
nerve at the upper and lower lip with the same stimulation electrode used for ABVN-SEP
(minimum 2 times 50 stimuli on each side of 0.2 ms duration, frequency 2.3 Hz, intensity 5–6
mA). Peak latencies of the early brainstem components of the AEP (I–V) and cortical compo-
nents of the TrigN-SEP (N13, P19, N27) were determined semi-automatically and used for fur-
ther statistical analyses.
Heart rate variability (HRV)
After at least 5 min of rest, RR intervals were measured on electrocardiograms at normal
breathing for 3 min under resting condition and for around 3 min during left or right transcu-
taneous ABVN stimulation (while ABVN-SEP were recorded) each in a pseudorandomized
order via the computer-based system ProScicard (Medset Medizintechnik GmbH, Hamburg,
Germany; [22]). Several indices of the heart rate variability (HRV) were automatically comput-
ed: number of all RR-intervals / maximal frequency (HRV index, higher index indicates higher
variability), power spectral analysis in the low (ln(LF), 0.05–0.15 Hz) and in the high frequency
spectrum (ln(HF), 0.15–0.5 Hz) and the low frequency/high frequency ratio (ln(LF/HF) ratio).
The HRV index and the ln(LF/HF) ratio at rest were considered as a marker of sympatho–
vagal interaction [22,23].
Statistical Analysis
Since Kolmogorov-Smirnov tests had indicated that EP data were normally distributed, a mul-
tivariate analysis of variance (MANOVA) was performed, separately for latencies and ampli-
tudes and for each bipolar recording site, respectively, using the factors “side” (left, right) and
“group” (PD, CTRL) for statistical analysis of the ABVN-SEP, AEP and TN-SEP data. For the
ABVN-SEP another analysis with “MoCA” as a covariate was performed, to control for effects
related to cognitive impairment (MANCOVA). The MAN(C)OVA analysis of the ABVN-SEP
data was also performed after having removed data over and above two standard deviations
(SD, with and without “MoCA” as a covariate).
Subjects with pacemaker were excluded from the experiment; subjects with arrhythmias
were excluded from the analysis. Explorative analysis of the HRV parameters revealed extreme
outliers (lacking biological plausibility). Therefore, extreme outliers were excluded based on
Tukey’s hinges (first quartile − 3  interquartile range (IQR) and third quartile + 3  IQR), visu-
alized in boxplots [24]. Repeated measures ANOVA (rmANOVA) were performed for the
HRV index and ln(LF/HF) ratio. Two-tailed t-tests were used for post hoc analysis. As ln(HF)
and ln(LF) data were not normally distributed, non-parametric tests were used. Friedman test
was applied to analyze the effect of CONDITION (rest, ABVN right, ABVN left) in each group
separately. Group differences (PD, CTRL) were tested using Mann-Whitney for every
condition separately.
Correlations between EP and HRV data and disease duration and UPDRS III were assessed
using linear regression analysis (Pearson’s correlation).
Data were tested for nonsphericity using Mauchly’s test. In case of lack of sphericity, p val-
ues were corrected using the Greenhouse–Geisser correction. The false discovery rate correc-
tion (FDRC, [25]) was applied to correct for multiple comparisons. Effects were considered
significant if p<0.05. All data are given as means ± SD. The statistics program used was SPSS
for windows (version 20.0).
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Results
Patient and control groups were matched in terms of age (PD, 64.3±9.0 years; CTRL, 64.2±11.2
years; p = 0.961), sex distribution (m/f, both 29/21), but differed slightly in cognitive capacity
as assessed by the MoCa test (PD, 24.6±3.1; CTRL, 25.8±2.7, p = 0.048). Disease stage was
2.3±0.7 on the Hoehn and Yahr scale, disease duration 6.4±4.5 years (range 1.0–20 years).
Patients scored 20.9±7.2 in the motor part of the Unified Parkinson’s Disease Rating Scale
(UPDRS III) and mean equivalent levodopa dose [26] was 707±480 mg.
ABVN-SEP were present with identifiable peaks P1, N1, and P2 in all patients, except one
(missing potentials after stimulation of the right ABVN), and all controls, except for missing
potentials after stimulation of the left ABVN in 3 control subjects and of the right ABVN in 5
control subjects. The MANOVA identified a significant factor “group” only for two recording
sites (Cz-A1/2; O1-T3/O2-T4) without correction for multiple comparisons each (four differ-
ent recording sites). When the effect of cognition was removed by using MoCA as covariate,
only one recording site (Cz-A1/2) remained significant. However, after FDRC, no significant
group difference survived (Fig. 3, Table 1, S1 Table). Overall, differences between groups were
numerically larger without consideration of cognition (MANOVA vs. MANCOVA), although
the factor MoCA itself was not significant. When the analysis was performed after removal of
outliers (data over and above 2 SD), again no differences were found between groups in any re-
cording site. MANOVA and MANCOVA did not reveal any differences of peak-to-peak am-
plitudes between groups in any recording site (Table 1, S1 Table).
Fig 3. ABVN-SEP recorded at the electrode position A1-Cz after electric stimulation of the auricular
branch of the left vagus nerve in a healthy control subject (dashed line) and a patient with Parkinson’s
disease (continuous line). P1 first positive peak, N1 first negative peak, P2 second positive peak.
doi:10.1371/journal.pone.0120786.g003
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MANOVA did not reveal any difference in AEP peak and interpeak latencies between PD
patients and controls. TrigN-SEP latencies were not different between both groups either
(Table 1).
No correlation of ABVN-SEP latencies and disease duration or UPDRS III was found in any
condition (data not shown).
HRV index was lower in PD patients compared to healthy controls (Table 2). It was not
altered by left or right ABVN stimulation in either group. These conclusions were supported
by a significant rmANOVA that revealed a significant main effect of GROUP (PD, CTRL;
F(1,31) = 10.184, p = 0.003), but no effect for the factor CONDITION (rest, ABVN right,
ABVN left; F(2,62) = 1.513, p = 0.228) or for the interaction GROUP  CONDITION
(F(2,62) = 0.851, p = 0.432).
Ln(LF) and ln(HF) were not influenced by ABVN stimulation in any group either (PD ln
(HF) χ2(2) = 1.556, p = 0.459; CTRL ln(HF) χ2(2) = 2.381, p = 0.304; PD ln(LF) χ2(2) = 1.841,
p = 0.398; CTRL ln(HF) χ2(2) = 1.614, p = 0.446). Ln(LF) and ln(HF) however, were lower in
PD patients compared to healthy controls in all conditions (apart from ln(LF) after left ABVN
stimulation, Table 2).
The ln(LF/HF) ratio did not differ between both groups either at rest and or during ABVN
stimulation (Table 2). These conclusions were supported by a non-significant rmANOVA for
the factor GROUP (F(1,28) = 2.196, p = 0.150) and the interaction GROUP  CONDITION
(F(2,56) = 0.323, p = 0.725). However, rmANOVA was significant for CONDITION (F(2,56) =
4.048, p = 0.023). Post-hoc t-test revealed a significant decrease of ln(LF/HF) ratio during right
ABVN stimulation in comparison to the resting condition across all subjects (p = 0.002), but
not following left VN stimulation (p = 0.238).
Table 1. Results of ABVN-SEP, AEP and TrigN-SEP.
main effect PD CTRL
ABVN-SEP latency [ms] group F(3,180) = 2.544 p = 0.058 P1 2.7 ± 0.5 2.8 ± 0.6
side F(3,180) = 0.792 p = 0.500 N1 4.5 ± 0.9 4.6 ± 1.0
group * side F(3,180) = 0.692 p = 0.558 P2 6.3 ± 1.2 6.1 ± 1.2
MoCA F(3,180) = 1.804 p = 0.148
amplitude[μV] group F(2,140) = 0.180 p = 0.835 P1-N1 11.8 ± 12.4 12.1 ± 11.3
side F(2,140) = 0.516 p = 0.598 N1-P2 6.8 ± 11.1 6.3 ± 6.4
group * side F(2,140) = 0.568 p = 0.568
MoCA F(2,140) = 0.491 p = 0.613
AEP latency [ms] group F(5,189) = 0.310 p = 0.906 I 1.8 ± 0.2 1.8 ± 0.2
side F(5,189) = 0.316 p = 0.903 II 3.0 ± 0.2 3.0 ± 0.1
group * side F(5,189) = 0.445 p = 0.817 III 4.0 ± 0.2 4.0 ± 0.2
IV 5.3 ± 0.2 5.2 ± 0.2
V 5.9 ± 0.2 5.9 ± 0.2
TrigN-SEP latency [ms] group F(3,193) = 0.659 p = 0.578 N13 13.9 ± 1.2 13.9 ± 1.0
side F(3,193) = 0.564 p = 0.639 P19 20.6 ± 1.6 20.4 ± 1.2
group * side F(3,193) = 1.882 p = 0.134 N27 28.1 ± 2.5 27.7 ± 1.5
Results of ABVN-SEP (recording site O1-T3/O2-T4), AEP (A1/2-Cz) and TrigN-SEP (C5/C6-Fz; mean ± SD). The main effect of the MAN(C)OVA for peak
latencies and amplitudes is indicated. There were no group differences between groups in the other recordings-sites either after correction for multiple
comparisons (ABVN-SEP). PD, patients with Parkinson’s disease; CTRL, healthy control subjects; ABVN-SEP, somatosensory evoked potentials
following electric stimulation of the auricular branch of the vagus nerve; AEP, auditory evoked potentials; TrigN-SEP, somatosensory evoked potentials
following electric stimulation of the trigeminal nerve.
doi:10.1371/journal.pone.0120786.t001
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HRV index and ln(LF/HF) ratio did not correlate with disease duration or UPDRS III.
UPDRS III correlated negatively with ln(LF) (r = −0.369, p = 0.014) and ln(HF) (r = −0.291,
p = 0.050) indicating a (weak) association between impairment in cardiac autonomic modula-
tions and motor deficit.
Discussion
Physiological examination of brainstem function by stimulation of the ABVN did not reveal
abnormalities in this population of PD patients compared to age and sex matched healthy con-
trols. ABVN-SEP did not discriminate between groups, and this was even more obvious when
cognition was considered as a covariate. Furthermore, ln(LF/HF) ratio, a measure sensitive to
cardiac parasympathetic tone, was modulated by ABVN stimulation, but similarly in PD pa-
tients and controls.
The present study has employed ABVN-SEP recording as a means of assessing VN function
[9]. The ABVN runs via the superior jugular ganglion into the medulla oblongata and to the
spinal trigeminal and solitary nucleus [27]. Anatomical specificity of this pathway is suggested
by the fact that ABVN-SEP potentials are blocked by application of local anesthetics in the
stimulation area [9]. The notion that the ABVN-SEP exhibit far-field potentials generated at the
brainstem level was recently challenged, as ABVN-SEP were found to disappear during neuro-
muscular blockade [28]. However, in a functional MRI study, brainstem activation along vagal af-
ferent pathways was seen following transcutaneous ABVN stimulation [29,30]. In addition, we
and others [9] observed that ABVN-SEP were only evoked following electrical stimulation of the
cutaneous representation of the ABVN, but not at the skin supplied by the trigeminal nerve or
the posterior auricular nerve, where myogenic potentials should also be evoked. Thus, we believe
ABVN-SEP to reflect neuronal activity within afferent brainstem pathways. According to Braak
and co-workers [1] in PD neuronal loss starts in the dorsal motor, efferent nucleus of the VN.
Visceroafferent nuclei of the solitary tract may also, at least in part, be affected [6], however, the
efferent nucleus ambiguous and afferent somatosensory nuclei remain spared. Normal ABVN-
SEP in PDmay then reflect absence of degeneration in neurons processing somatosensory affer-
ent information. The general integrity of sensory brainstem and cortical pathways is also sup-
ported by the fact that no abnormalities were found in AEP [31] (but see [32]) and TrigN-SEP
(not to our knowledge examined in PD before), respectively. As we did not investigate early
(brainstem) components of the TrigN-SEP described previously [33], the present data allow for
only indirect conclusions regarding the explicit sensory trigeminal brainstem pathway.
Our results appear to be at variance with previous findings obtained in a small sample of PD
patients which demonstrated partially prolonged ABVN-SEP latencies, after left ABVN stimu-
lation [11]. Because in the present study, the sensitivity to detect ABVN-SEP changes was en-
hanced by additional recording sites (established for recording of far field potentials such as
AEPs), methodological factors are unlikely to explain this discrepancy. Prolonged latencies of
ABVN-SEP have been described in previous studies in patients with AD compared to healthy
controls [13,34], where degeneration of the vagal nuclei complex, possibly including parts pro-
cessing somatosensory afferents, is present early in the disease course [14]. It, therefore, is con-
ceivable that prolonged ABVN-SEP latencies found previously in PD patients [11] may reflect
the co-presence of Alzheimer and PD pathology in these patients. In the present study, the
range of cognitive scores in PD patients was small, as all patients had normal or near-normal
cognition. This, and variable co-expression of Alzheimer pathology in cognitively impaired PD
may explain why cognition did not emerge as a significant factor in our analysis.
Afferent and efferent parts of the vagal nuclei complex are closely functionally interconnec-
ted [27,35]. Vomiting, cough or even syncope may be induced by mechanical stimulation of
Auricular Branch of Vagus Nerve Stimulation in PD
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the external acoustic meatus ("Arnold’s reflex" [16,36]) and such modulation of the cardiac
parasympathetic autonomic pathways is an emerging therapeutic approach for cardiac disor-
ders [17,19,18,37]. Recently, Clancy and colleagues demonstrated that cardioautonomic func-
tion was shifted toward parasympathetic predominance following electrical stimulation of the
ABVN [15]. We found ln(LF/HF) ratio to be reduced by ABVN stimulation in healthy controls.
Because the ln(LF/HF) ratio is believed to mirror sympathovagal balance [22], this observation
may suggest that parasympathetic activity is relatively enhanced over sympathetic activity by af-
ferent cutaneous stimulation, a finding in line with human studies [15] and observations in ani-
mals [38] although neither ln(HF), a marker for sympathetic activity [22], nor ln(HF), a marker
for parasympathetic activity [22], were markedly modulated by ABVN stimulation. Specificity of
this finding is suggested by the fact that only right, but not left ABVN stimulation was capable of
modulating ln(LF/HF) ratio. Cardiac parasympathetic innervation of the sinoatrial node (and,
therefore, modulation of heart beat frequency) is mainly subserved by nerve fibers emanating
from right brainstem vagus nuclei [4]. Importantly, we found that modulation of ln(LF/HF) ratio
by right ABVN stimulation was fully retained in PD patients. This observation provides an indi-
rect clue that vagal nuclei complex function may in fact not be severely functionally compro-
mised in PD. Preserved capacity for the cutaneo-autonomic pathway may indicate intact
function of the nucleus ambiguous which, as noted above, is relatively spared in PD [1,6]. Alter-
natively, as DMN is involved also in regulating cardiac activity [4,3], retained cutaneo-autonomic
reflex function as indexed by ln(LF/HF) ratio may indicate less degeneration of DMN than previ-
ously thought. In line with the latter conclusion, some authors have argued that DMN is not se-
verely affected by alpha-synuclein pathology in early disease stages of PD [39,40].
Despite retained cutaneo-autonomic modulation, PD patients had evidence of subclinical
autonomic dysfunction as shown by a decrease of different HRV indices, in agreement with
previous studies [41–43]. Changes of HRV in PD may at least in part be due to sympathetic
cardiac denervation [44,43,45]. However, impairment of HRV did not correlate with postgan-
glionic cardiac denervation as revealed by cardiac scintigraphy [45,43]. Intact ABVN-SEP and
intact modulation of parasympathetic tone by ABVN-stimulation may then suggest that auto-
nomic dysfunction either starts in the peripheral autonomic system [46], or is related to nor-
epinephrine loss in the central sympathetic nervous system [47].
In conclusion, the present study has not provided evidence favoring malfunctioning of
ABVN or cutaneo-autonomic reflex operation involving the ABVN in PD patients. The senso-
ry part of the VN may not be functionally affected in PD.
Supporting Information
S1 Table. Results of ABVN-SEP at the recording site Fz-F3/F4, C3-F3/C4-F4, Cz-A1/A2).
The main effect of the MANCOVA for peak latencies and amplitudes is indicated. There were no
group differences between groups either after correction for multiple comparisons (ABVN-SEP).
PD, patients with Parkinson’s disease; CTRL, healthy control subjects; ABVN-SEP, somatosenso-
ry evoked potentials following electric stimulation of the auricular branch of the vagus nerve.
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